Friday, 4 January 2019

Home » » Bristol Myers and Celgene in $74bn pharmaceutical merger

Bristol Myers and Celgene in $74bn pharmaceutical merger

By  January 04, 2019  No comments
Two leading US cancer drug companies announce a blockbuster tie-up valued at more than $74bn.

https://ift.tt/eA8V8J
from USA BULK NEWS

0 comments:

Post a Comment

Note: only a member of this blog may post a comment.